Literature DB >> 19733958

EAU guidelines on chronic pelvic pain.

Magnus Fall1, Andrew P Baranowski, Sohier Elneil, Daniel Engeler, John Hughes, Embert J Messelink, Frank Oberpenning, Amanda C de C Williams.   

Abstract

CONTEXT: These guidelines were prepared on behalf of the European Association of Urology (EAU) to help urologists assess the evidence-based management of chronic pelvic pain (CPP) and to incorporate the recommendations into their clinical practice.
OBJECTIVE: To revise guidelines for the diagnosis, therapy, and follow-up of CPP patients. EVIDENCE ACQUISITION: Guidelines were compiled by a working group and based on a systematic review of current literature using the PubMed database, with important papers reviewed for the 2003 EAU guidelines as a background. A panel of experts weighted the references. EVIDENCE SYNTHESIS: The full text of the guidelines is available through the EAU Central Office and the EAU Web site (www.uroweb.org). This article is a short version of the full guidelines text and summarises the main conclusions from the guidelines on the management of CPP.
CONCLUSIONS: A guidelines text is presented including chapters on chronic prostate pain and bladder pain syndromes, urethral pain, scrotal pain, pelvic pain in gynaecologic practice, neurogenic dysfunctions, the role of the pelvic floor and pudendal nerve, psychological factors, general treatment of CPP, nerve blocks, and neuromodulation. These guidelines have been drawn up to provide support in the management of the large and difficult group of patients suffering from CPP.

Entities:  

Mesh:

Year:  2009        PMID: 19733958     DOI: 10.1016/j.eururo.2009.08.020

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  90 in total

Review 1.  Recognition and management of nonrelaxing pelvic floor dysfunction.

Authors:  Stephanie S Faubion; Lynne T Shuster; Adil E Bharucha
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain.

Authors:  Meryl J Alappattu; Mark D Bishop
Journal:  Phys Ther       Date:  2011-08-11

3.  The negative effect of urologic chronic pelvic pain syndrome on female sexual function: a systematic review and meta-analysis.

Authors:  Yupeng Guan; Gang Yu; Guoren Wang; Zhiming Bai
Journal:  Int Urogynecol J       Date:  2019-06-21       Impact factor: 2.894

4.  Intravesical treatment of painful bladder syndrome: the potential pitfalls of meta-analyses.

Authors:  Sanjay Sinha
Journal:  Int Urogynecol J       Date:  2012-05-09       Impact factor: 2.894

Review 5.  Chronic Scrotal Pain.

Authors:  Christopher Wu; Keith Jarvi
Journal:  Curr Urol Rep       Date:  2018-05-31       Impact factor: 3.092

6.  Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada.

Authors:  J Curtis Nickel; Dean Tripp; Allan Gordon; Michel Pontari; Daniel Shoskes; Kenneth M Peters; Ragi Doggweiler; Andrew Paul Baranowski
Journal:  Rev Urol       Date:  2011

Review 7.  [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

Authors:  A Gonsior; J Neuhaus; L C Horn; T Bschleipfer; J-U Stolzenburg
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

8.  A directional preference approach for chronic pelvic pain, bladder dysfunction and concurrent musculoskeletal symptoms: a case series.

Authors:  Christine Hughes; Stephen May
Journal:  J Man Manip Ther       Date:  2019-11-08

9.  [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

Authors:  M Walter; U Sammer; T M Kessler
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

10.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.